Eric Olivares - GeneDx Holdings Chief Officer
Executive
Eric Olivares is Chief Officer of GeneDx Holdings Corp
| Phone | 888 729 1206 |
| Web | https://www.genedx.com |
GeneDx Holdings Management Efficiency
The company has return on total asset (ROA) of (0.032) % which means that it has lost $0.032 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.221) %, meaning that it generated substantial loss on money invested by shareholders. GeneDx Holdings' management efficiency ratios could be used to measure how well GeneDx Holdings manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 6 records | EXECUTIVE Age | ||
| Harold Alterson | Humacyte | N/A | |
| SPHR GPHR | Humacyte | N/A | |
| Yang MD | Humacyte | 59 | |
| Shamik MD | Humacyte | 52 | |
| William Scheessele | Humacyte | 53 | |
| Sabrina Osborne | Humacyte | N/A | |
Management Performance
| Return On Equity | -0.22 | ||||
| Return On Asset | -0.032 |
GeneDx Holdings Corp Leadership Team
Elected by the shareholders, the GeneDx Holdings' board of directors comprises two types of representatives: GeneDx Holdings inside directors who are chosen from within the company, and outside directors, selected externally and held independent of GeneDx. The board's role is to monitor GeneDx Holdings' management team and ensure that shareholders' interests are well served. GeneDx Holdings' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, GeneDx Holdings' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Daniel JD, Secretary | ||
| Heidi JD, Chief Officer | ||
| Britt Johnson, Head Affairs | ||
| Katherine Stueland, CEO President | ||
| Jami Biliboaca, Head Strategy | ||
| Eric Olivares, Chief Officer | ||
| Tricia Truehart, Head Relations | ||
| MBA JD, General Counsel | ||
| Bryan Dechairo, Chief Officer | ||
| FACMG MD, Chief Officer | ||
| Sabrina Dunbar, Chief Staff | ||
| Jerry Conway, Senior Access | ||
| Kevin Feeley, Chief Officer | ||
| Paul MD, Chief Officer | ||
| Melanie Duquette, Chief Officer | ||
| Jennifer Brendel, Chief Affairs | ||
| Feras Hantash, Senior Oncology | ||
| Kevin CPA, Chief Officer | ||
| Jason Ryan, Executive Board | ||
| Karen Ponchner, Senior Operations |
GeneDx Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is GeneDx Holdings a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.22 | ||||
| Return On Asset | -0.032 | ||||
| Profit Margin | (0.17) % | ||||
| Operating Margin | 0.11 % | ||||
| Number Of Shares Shorted | 3.67 K | ||||
| Revenue | 305.45 M | ||||
| Gross Profit | 194.45 M | ||||
| EBITDA | (23.21 M) | ||||
| Net Income | (52.29 M) | ||||
| Total Debt | 64.25 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Your Current Watchlist to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in housing. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Other Tools for GeneDx Stock
When running GeneDx Holdings' price analysis, check to measure GeneDx Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GeneDx Holdings is operating at the current time. Most of GeneDx Holdings' value examination focuses on studying past and present price action to predict the probability of GeneDx Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GeneDx Holdings' price. Additionally, you may evaluate how the addition of GeneDx Holdings to your portfolios can decrease your overall portfolio volatility.
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |